Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $8.54 billion as of November 26, 2025. Its market cap has increased by 9.94% in one year.

• Market Cap: 8.54B
• Enterprise Value: 9.38B
• 1-Year Change: 9.94%
• Ranking: #993
• Category: Mid-Cap
• Stock Price: $72.66

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $8.54B, an increase of 105,388.86%. That is a compound annual growth rate of 37.80%.

Market Cap History

Date	Market Cap	% Change
Nov 26, 2025	8.54B	40.47%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%
Mar 16, 2004	8.10M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	958.20B
Johnson & Johnson	496.44B
AbbVie	405.63B
UnitedHealth Group	289.01B
AstraZeneca	283.06B
Merck & Co.	249.20B
Novartis AG	244.50B
Abbott Laboratories	221.17B